Articles related to Oncology, Surgical

Explore the latest insights from ASCO GU 2024 on first-line treatments for advanced renal cell carcinoma, including the effectiveness of combination therapies and the pressing need to address racial disparities in patient outcomes.

Mirvetuximab soravtansine represents a pivotal shift in treating platinum-resistant ovarian cancer, demonstrating not only improved survival outcomes but also a higher response rate compared to standard chemotherapy.

A radiologist’s failure to detect early-stage cancer exemplifies the profound implications of diagnostic accuracy in radiology, emphasizing the necessity for vigilance in interpreting imaging studies to prevent catastrophic outcomes.

The Supreme Court’s deliberations on the Chevron deference and FDA’s drug approval authority underscore a critical juncture for healthcare delivery and regulatory practices, potentially reshaping physician autonomy and patient care standards.

Abdominal cancer is no longer an ailment confined to older demographics, with a notable uptick in cases among younger adults. Physicians are urged to consider early screening, especially for patients with familial cancer histories, amidst growing concerns over lifestyle and environmental influences.

The combination of ribociclib and a nonsteroidal aromatase inhibitor was associated with a notable improvement in invasive disease–free survival rates among early-stage, HR-positive, HER2-negative breast cancer patients, highlighting a significant advancement in the therapeutic landscape of this common malignancy.